A Phase 1b, Single-Dose, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HemaMax (rHuIL-12) in Healthy Subjects
Latest Information Update: 24 Nov 2018
At a glance
- Drugs NMIL 12 1 (Primary)
- Indications Acute radiation syndrome
- Focus Adverse reactions
- Sponsors Neumedicines
- 01 Apr 2014 New trial record